These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26542377)

  • 41. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanisms of insulin resistance].
    Mäkinen S; Skrobuk P; Nguyen YH; Koistinen H
    Duodecim; 2013; 129(20):2115-22. PubMed ID: 24340711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Mitochondrial Approach to Cardiovascular Risk and Disease.
    Veloso CD; Belew GD; Ferreira LL; Grilo LF; Jones JG; Portincasa P; Sardão VA; Oliveira PJ
    Curr Pharm Des; 2019; 25(29):3175-3194. PubMed ID: 31470786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
    Ramalingam L; Menikdiwela K; LeMieux M; Dufour JM; Kaur G; Kalupahana N; Moustaid-Moussa N
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1106-1114. PubMed ID: 27497523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
    Vlassara H; Cai W; Tripp E; Pyzik R; Yee K; Goldberg L; Tansman L; Chen X; Mani V; Fayad ZA; Nadkarni GN; Striker GE; He JC; Uribarri J
    Diabetologia; 2016 Oct; 59(10):2181-92. PubMed ID: 27468708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
    Hanley AJ; Retnakaran R; Qi Y; Gerstein HC; Perkins B; Raboud J; Harris SB; Zinman B
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3824-32. PubMed ID: 19622625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
    Ibarra-Lara L; Sánchez-Aguilar M; Sánchez-Mendoza A; Del Valle-Mondragón L; Soria-Castro E; Carreón-Torres E; Díaz-Díaz E; Vázquez-Meza H; Guarner-Lans V; Rubio-Ruiz ME
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28036029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?
    Chen G; Liu C; Chen F; Yao J; Jiang Q; Chen N; Huang H; Liang J; Li L; Lin L
    Int J Clin Pract; 2011 May; 65(5):592-601. PubMed ID: 21489083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The insulin-like growth factor system, metabolic syndrome, and cardiovascular disease risk.
    Akanji AO; Smith RJ
    Metab Syndr Relat Disord; 2012 Feb; 10(1):3-13. PubMed ID: 22103319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thioredoxins in cardiovascular disease.
    Whayne TF; Parinandi N; Maulik N
    Can J Physiol Pharmacol; 2015 Nov; 93(11):903-11. PubMed ID: 26417924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerobic exercise regulates blood lipid and insulin resistance via the toll‑like receptor 4‑mediated extracellular signal‑regulated kinases/AMP‑activated protein kinases signaling pathway.
    Wang M; Li S; Wang F; Zou J; Zhang Y
    Mol Med Rep; 2018 Jun; 17(6):8339-8348. PubMed ID: 29658605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of Oxidative Stress in Metabolic Syndrome.
    Masenga SK; Kabwe LS; Chakulya M; Kirabo A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin Resistance, Obesity and Lipotoxicity.
    Yazıcı D; Sezer H
    Adv Exp Med Biol; 2017; 960():277-304. PubMed ID: 28585204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.